Stable Gastric Pentadecapeptide BPC 157 and Wound Healing [PDF]
Frontiers in Pharmacology, 2021 Significance: The antiulcer peptide, stable gastric pentadecapeptide BPC 157 (previously employed in ulcerative colitis and multiple sclerosis trials, no reported toxicity (LD1 not achieved)), is reviewed, focusing on the particular skin wound therapy ...
Ivan Krezić +2 more
exaly +12 more sources
Pentadecapeptide BPC 157 and the central nervous system [PDF]
Neural Regeneration Research, 2022 We reviewed the pleiotropic beneficial effects of the stable gastric pentadecapeptide BPC 157, three very recent demonstrations that may be essential in the gut-brain and brain-gut axis operation, and therapy application in the central nervous system ...
Jakša Vukojevic +11 more
doaj +7 more sources
Stable Gastric Pentadecapeptide BPC 157 and Striated, Smooth, and Heart Muscle [PDF]
Biomedicines, 2022 First, we review the definitively severed myotendinous junction and recovery by the cytoprotective stable gastric pentadecapeptide BPC 157 therapy, its healing that might combine both transected and detached tendon and transected muscle, ligament and ...
Antonio Kokot +2 more
exaly +9 more sources
The effect of pentadecapeptide BPC 157 on hippocampal ischemia/reperfusion injuries in rats [PDF]
Brain and Behavior, 2020 Background and purpose We focused on the, yet undescribed, therapy effect of the stable gastric pentadecapeptide BPC 157 in hippocampal ischemia/reperfusion injuries, after bilateral clamping of the common carotid arteries in rats.
Jakša Vukojević +10 more
doaj +7 more sources
In relation to NO-System, Stable Pentadecapeptide BPC 157 Counteracts Lidocaine-Induced Adverse Effects in Rats and Depolarisation In Vitro [PDF]
Emergency Medicine International, 2020 Recently, the pentadecapeptide BPC 157-induced counteraction of bupivacaine cardiotoxicity has been reported. Medication includes (i) lidocaine-induced local anesthesia via intraplantar application and axillary and spinal (L4-L5) intrathecal block, (ii ...
Marin Lozic +16 more
doaj +3 more sources
Stable Gastric Pentadecapeptide BPC 157 Therapy for Monocrotaline-Induced Pulmonary Hypertension in Rats Leads to Prevention and Reversal [PDF]
Biomedicines, 2021 Background. Monocrotaline selectively injures the lung’s vascular endothelium and induces pulmonary arterial hypertension. The stable gastric pentadecapeptide BPC 157 acts as a prototype cytoprotective agent that maintains endothelium, and its ...
Dean Strinic +2 more
exaly +4 more sources
Antiarrhythmic Sotalol, Occlusion/Occlusion-like Syndrome in Rats, and Stable Gastric Pentadecapeptide BPC 157 Therapy [PDF]
Pharmaceuticals, 2023 We focused on the first demonstration that antiarrhythmics, particularly class II and class III antiarrhythmic and beta-blocker sotalol can induce severe occlusion/occlusion-like syndrome in rats.
Ivica Premuzic Mestrovic +2 more
exaly +4 more sources
Stable Gastric Pentadecapeptide BPC 157 Heals Established Vesicovaginal Fistula and Counteracts Stone Formation in Rats [PDF]
Biomedicines, 2021 With the stable gastric pentadecapeptide BPC 157 therapy known to heal various both external and internal rat fistulas, we attempt to approach vesicovaginal fistula, continuous urine leaking through vagina, bladder stones, and a possible therapy solution
Domagoj Rasic +2 more
exaly +4 more sources
Stable Gastric Pentadecapeptide BPC 157 May Counteract Myocardial Infarction Induced by Isoprenaline in Rats [PDF]
Biomedicines, 2022 We revealed that the stable gastric pentadecapeptide BPC 157, a useful peptide therapy against isoprenaline myocardial infarction, as well as against isoprenaline myocardial reinfarction, may follow the counteraction of the recently described occlusion ...
Lozić Marin +2 more
exaly +4 more sources
Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in Rats [PDF]
Frontiers in Pharmacology, 2021 Recently, the stable gastric pentadecapeptide BPC 157 was shown to counteract major vessel occlusion syndromes, i.e., peripheral and/or central occlusion, while activating particular collateral pathways.
Göran Santak +2 more
exaly +4 more sources